The next focusIR Investor Webinar takes places on 14th May with guest speakers from Blue Whale Growth Fund, Taseko Mines, Kavango Resources and CQS Natural Resources fund. Please register here.

Less Ads, More Data, More Tools Register for FREE

Pin to quick picksVersarien Regulatory News (VRS)

Share Price Information for Versarien (VRS)

London Stock Exchange
Share Price is delayed by 15 minutes
Get Live Data
Share Price: 0.103
Bid: 0.098
Ask: 0.103
Change: 0.0015 (1.52%)
Spread: 0.005 (5.102%)
Open: 0.103
High: 0.103
Low: 0.103
Prev. Close: 0.099
VRS Live PriceLast checked at -

Watchlists are a member only feature

Login to your account

Alerts are a premium feature

Login to your account

Placing to raise £400,000

19 Jan 2024 07:00

RNS Number : 2199A
Versarien PLC
19 January 2024
 

THIS ANNOUNCEMENT CONTAINS INSIDE INFORMATION FOR THE PURPOSES OF THE MARKET ABUSE REGULATION (EU) 596/2014 (AS AMENDED) AS IT FORMS PART OF THE DOMESTIC LAW OF THE UNITED KINGDOM BY VIRTUE OF THE EUROPEAN UNION (WITHDRAWAL) ACT 2018 (AS AMENDED). UPON PUBLICATION OF THIS ANNOUNCMENT, THIS INSIDE INFORMATION IS NOW CONSIDERED TO BE IN THE PUBLIC DOMAIN.

 

19 January 2024

 

Versarien plc

 

("Versarien" or the "Company")

 

Placing to raise £400,000

 

Versarien plc (AIM: VRS), the advanced materials engineering group, announces it has raised £400,000 (before expenses) by way of a placing (the "Placing") of 500,000,000 new ordinary shares in the capital of the Company ("Placing Shares") at a price of 0.08 pence per share (the "Placing Price").

 

Highlights

 

· Versarien has raised £400,000, before expenses, through the placing of 500,000,000 new ordinary shares in the capital of the Company at a price of 0.08 pence per share

· The net proceeds of the Placing will be used for corporate and working capital purposes as the Company seeks to capitalise on the growing number of opportunities in its pipeline whilst continuing to progress its asset sales

· The issue of the Placing Shares is within existing authorities granted by shareholders at the general meeting of the Company held on 10 January 2024 and therefore no shareholder approval is required for the Placing

 

Use of Proceeds and Turnaround Strategy

 

The net proceeds of the Placing will be used for corporate and working capital purposes as the Company seeks to capitalise on the growing number of opportunities in its pipeline. Recent new projects include a sales agreement with Go To Gym to bring Graphene-WearTM products to Colombia, Brazil and the USA, and Versarien's subsidiary, Gnanomat, entering into an agreement to co-develop advanced materials with IRPC, a Thai petroleum and petrochemical company. These projects, along with a pipeline of other opportunities currently being pursued demonstrate the longer term prospects for the business.

 

As announced on 20 December 2023, the mature businesses and the intellectual property and plant acquired from Hanwha Aerospace in 2020 continue to be marketed for sale and the Company is progressing discussions with a number of interested parties, though the timing of any asset sales and the quantum of the funds that may be received remains uncertain.

 

Stephen Hodge, Chief Executive Officer of Versarien, commented:

 

"In the short time since the Company Update announced on 20 December, the commercial, licencing and grant opportunities have continued to grow. This further funding will help us to progress the conversion of these leads while the asset sale discussions continue. We look forward to updating the market in due course."

 

Admission and Total Voting Rights

 

Application has been made for admission of the Placing Shares to be admitted to trading on AIM ("Admission") on or around 24 January 2024. The Placing Shares will rank pari passu in all respects with the Company's existing ordinary shares. Following Admission, the total number of ordinary shares in the Company in issue will be 996,169,507. This figure may be used by shareholders as the denominator for the calculations by which they will determine if they are required to notify their interest in, or a change to their interest in the Company under the FCA's Disclosure and Transparency Rules.

 

For further information please contact:

 

Versarien

Stephen Hodge, Chief Executive Officer

Chris Leigh, Chief Financial Officer

 

c/o IFC

SP Angel Corporate Finance (Nominated Adviser and Broker)

Matthew Johnson, Adam Cowl

+44 (0)20 3470 0470

 

 

IFC Advisory Limited (Financial PR and Investor Relations)

Tim Metcalfe, Zach Cohen

+44 (0) 20 3934 6630

 

About Versarien:

 

The strategy of Versarien plc (AIM:VRS) is to be a development led advanced materials company focussed on specific sectors that will lead to a light manufacturing and licensing model.

 

For further information please see: http://www.versarien.com

 

 

This information is provided by RNS, the news service of the London Stock Exchange. RNS is approved by the Financial Conduct Authority to act as a Primary Information Provider in the United Kingdom. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact rns@lseg.com or visit www.rns.com.RNS may use your IP address to confirm compliance with the terms and conditions, to analyse how you engage with the information contained in this communication, and to share such analysis on an anonymised basis with others as part of our commercial services. For further information about how RNS and the London Stock Exchange use the personal data you provide us, please see our Privacy Policy.
 
END
 
 
IOEGPUGWGUPCPGR
Date   Source Headline
19th Oct 20204:41 pmRNSSecond Price Monitoring Extn
19th Oct 20204:35 pmRNSPrice Monitoring Extension
16th Oct 20205:18 pmRNSHolding(s) in Company
29th Sep 20207:00 amRNSAdvisory Panel
24th Sep 202012:07 pmRNSResult of AGM
23rd Sep 20207:00 amRNSPosting of Annual Report
1st Sep 20207:00 amRNSNotice of AGM
17th Aug 20207:00 amRNSUpdate re. Innovate UK Loan Agreement
11th Aug 20207:00 amRNSPreliminary Results
3rd Aug 20207:00 amRNSLaunch of Graphene Enhanced Protective Face Mask
1st Jul 20207:01 amRNS£5 million Innovate UK Loan Agreement
1st Jul 20207:00 amRNSCorporate Update and Notice of Results
19th Jun 20207:00 amRNSAppointment of Non-executive Chairman
12th Jun 20209:41 amRNSInvestor Communication
4th Jun 202012:02 pmRNSPrice Monitoring Extension
19th May 202012:07 pmRNSSecond Price Monitoring Extn
19th May 202012:02 pmRNSPrice Monitoring Extension
18th May 20204:41 pmRNSSecond Price Monitoring Extn
18th May 20204:36 pmRNSPrice Monitoring Extension
28th Apr 202011:17 amRNS2-DTech awarded grant
23rd Apr 20207:00 amRNSRolls-Royce chooses to partner with GEIC & 2-DTech
15th Apr 20205:10 pmRNSHolding(s) in Company
6th Apr 20207:00 amRNSClarification: Sharing Agreement & China JV
2nd Apr 20203:32 pmRNSHolding(s) in Company
31st Mar 202012:08 pmRNSSecond Price Monitoring Extn
31st Mar 202012:02 pmRNSPrice Monitoring Extension
31st Mar 20207:00 amRNSTotal Voting Rights
30th Mar 20207:00 amRNSHolding(s) in Company
27th Mar 20202:05 pmRNSSecond Price Monitoring Extn
27th Mar 20202:00 pmRNSPrice Monitoring Extension
26th Mar 202011:05 amRNSSecond Price Monitoring Extn
26th Mar 202011:00 amRNSPrice Monitoring Extension
25th Mar 20202:05 pmRNSSecond Price Monitoring Extn
25th Mar 20202:00 pmRNSPrice Monitoring Extension
25th Mar 202011:05 amRNSSecond Price Monitoring Extn
25th Mar 202011:00 amRNSPrice Monitoring Extension
25th Mar 20207:00 amRNSChina Update
23rd Mar 20203:06 pmRNSInvestor Communications
23rd Mar 20207:00 amRNSSubscription to raise £6 million
4th Mar 20204:40 pmRNSSecond Price Monitoring Extn
4th Mar 20204:35 pmRNSPrice Monitoring Extension
3rd Mar 20204:40 pmRNSSecond Price Monitoring Extn
3rd Mar 20204:36 pmRNSPrice Monitoring Extension
28th Feb 20207:00 amRNSInvestor Communications
26th Feb 202011:05 amRNSSecond Price Monitoring Extn
26th Feb 202011:00 amRNSPrice Monitoring Extension
25th Feb 20201:48 pmRNSCorporate update
18th Feb 20204:15 pmRNSChange of Substantial Shareholding
17th Feb 20207:00 amRNSChange of Nominated Adviser and Broker
12th Feb 20204:40 pmRNSSecond Price Monitoring Extn

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.

Login to your account

Don't have an account? Click here to register.

Quickpicks are a member only feature

Login to your account

Don't have an account? Click here to register.